# Diclofenac for Submassive PE

> **NCT01590342** · PHASE2,PHASE3 · TERMINATED · sponsor: **Ministry of Health, Spain** · enrollment: 34 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Diclofenac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01590342
- **Lead sponsor:** Ministry of Health, Spain
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2017-01
- **Final completion:** 2017-06
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Low recruitment rate
- **Last updated:** 2017-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01590342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01590342, "Diclofenac for Submassive PE". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01590342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*